Acurx Pharmaceuticals (ACXP) Misses Q1 EPS by 62c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.62).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR) Following Sector Deal
• Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters